AJR 2002; 179:802-803
© American Roentgen Ray Society
ANNA-1Induced Encephalitis Associated with Noninvasive Thymoma
Michael P. Buetow and
Eric Eggenberger
Lansing Radiology Associates, Sparrow Health System, Lansing, MI
48912
Michigan State University, East Lansing, MI 48824
A 34-year-old woman presented with leg paresthesias and subsequently
developed focal seizures and nearly fixed pupils. An MR imaging examination of
the patient's brain revealed multiple gray matter lesions as hyperintense foci
on T2-weighted fast spin-echo and fluid-attentuation inversion recovery
(FLAIR) images (Figs.
1A,1B,1C).
No enhancement of the lesions occurred after the administration of gadolinium,
and none of the lesions revealed a mass effect. Abnormal findings were most
pronounced in regions of the temporal lobes, primarily in the limbic cortex,
but were also seen in the frontal and occipital lobes. A chest radiograph and
enhanced chest CT scan (Fig.
1D) revealed an anterior mediastinal mass. Results of a test for
the ANNA-1 (type 1 antineuronal nuclear antibody, or anti-Hu antibody) were
positive. A thoracotomy was performed, a typical noninvasive thymoma was
removed, and the patient's symptoms improved. Findings of follow-up brain MR
imaging 2 months later were normal, showing resolution of the brain
lesions.

View larger version (132K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 1A. 34-year-old woman who presented with diverse neurologic
symptoms. Axial T2-weighted fast spin-echo MR image shows hyperintense lesions
(arrows) distributed along insular cortex of right temporal lobe with
dominant lesion (arrowhead) involving left temporal lobe.
|
|

View larger version (130K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 1B. 34-year-old woman who presented with diverse neurologic
symptoms. Axial fluid-attenuated inversion recovery (FLAIR) image obtained at
same level as A more clearly depicts dominant left temporal lesion
(arrowhead) and lesions (arrows) along right insular
cortex.
|
|

View larger version (136K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 1C. 34-year-old woman who presented with diverse neurologic
symptoms. Axial FLAIR image reveals right occipital lesion (arrow).
None of the lesions enhanced with administration of gadolinium.
|
|

View larger version (118K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 1D. 34-year-old woman who presented with diverse neurologic
symptoms. Enhanced CT scan of chest shows well-circumscribed soft-tissue mass
(arrow) located in anterior mediastinum that proved to be noninvasive
thymoma.
|
|
ANNA-1 is a marker of paraneoplastic neurologic diseases and is commonly
associated with small cell lung carcinoma. The presence of the marker is
sometimes caused by other malignancies, such as invasive thymoma, and is
rarely associated with benign noninvasive thymoma
[1,2,3].
The most common clinical manifestations related to ANNA-1 include peripheral
neuropathy, cerebellar dysfunction, limbic encephalitis (including focal
seizures), cranial neuropathy (typically affecting ocular motor functioning),
and gastrointestinal symptoms (gut dysmotility). Myopathy and Lambert-Eaton
syndrome are seen less frequently
[2,
4]. The MR imaging appearance
of ANNA-1 paraneoplastic syndrome varies. In cases in which ANNA-1 is
associated with the clinical syndrome of limbic encephalitis, brain MR imaging
has been reported to reveal abnormalitiestypically involving only the
temporal lobesin approximately half of the patients imaged
[5]. Enhancement occurs in up
to 20% of patients, and extratemporal involvement is seen in fewer than 10% of
patients. Biopsy of the cortical lesions has shown perivascular and
parenchymal inflammatory cell infiltrates with neuronal loss, with no evidence
of neoplasia [6].
Although the appearance of ANNA-1induced encephalitis on MR imaging
is not pathognomonic, findings of cortical-based non-enhancing lesions, most
pronounced in the temporal lobes, are unique. A search for an
ANNA-1-associated malignancy, particularly in the mediastinum, should
be considered. Unfortunately, the most common cause of the ANNA-1 marker is
small cell lung carcinoma, which has a poor prognosis. In rare cases such as
in this patient, a curable lesion, such as thymoma, is the source of the
encephalitis.
References
- Lucchinetti CF, Kimmel DW, Lennon VA. Paraneoplastic and oncologic
profiles of patients seropositive for type 1 antineuronal nuclear
autoantibodies. Neurology
1998;50:652
-657[Abstract/Free Full Text]
- Evoli A, Lo Monaco M, Marra R, Lino MM, Batocchi AP, Tonali PA.
Multiple paraneoplastic diseases associated with thymoma.
Neuromuscul Disord
1999;9:601
-603[Medline]
- Vernino S, Eggenberger E, Rogers L, Lennon VA. Paraneoplastic
neurological autoimmunity associated with ANNA-1 autoantibody and thymoma.
Neurology 2002 (in
press)
- Hinton RC. Paraneoplastic neurologic syndromes. Hematol
Oncol Clin North Am
1996;10:909
-926[Medline]
- Gultekin SH, Rosenfeld MR, Voltz R, Eichen J, Posner JB, Dalmau J.
Paraneoplastic limbic encephalitis: neurological symptomsimmunologic
findings and tumor association in 50 patients. Brain
2000;123:1481
-1491[Abstract/Free Full Text]
- Alamowitch S, Graus F, René R, Bescansa E, Delattre JY.
Limbic encephalitis and small cell lung cancer: clinical and immunologic
features. Brain
1997;120:923
-928[Abstract/Free Full Text]

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?